Julia Kathleen Rotow, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carcinoma, Non-Small-Cell Lung | 15 | 2024 | 5321 | 1.900 |
Why?
|
Lung Neoplasms | 23 | 2024 | 13385 | 1.660 |
Why?
|
Acrylamides | 2 | 2024 | 259 | 0.980 |
Why?
|
Proto-Oncogene Proteins c-met | 2 | 2019 | 566 | 0.970 |
Why?
|
Oncogene Protein p21(ras) | 1 | 2019 | 68 | 0.670 |
Why?
|
Exons | 2 | 2019 | 2380 | 0.540 |
Why?
|
Drug Resistance, Neoplasm | 6 | 2024 | 5300 | 0.530 |
Why?
|
Indoles | 2 | 2024 | 1830 | 0.530 |
Why?
|
Protein Kinase Inhibitors | 8 | 2024 | 5662 | 0.490 |
Why?
|
Aniline Compounds | 3 | 2024 | 1073 | 0.460 |
Why?
|
MAP Kinase Signaling System | 2 | 2019 | 1480 | 0.430 |
Why?
|
Mutation | 16 | 2024 | 30002 | 0.400 |
Why?
|
Pyrimidines | 2 | 2024 | 3027 | 0.400 |
Why?
|
Neoadjuvant Therapy | 2 | 2024 | 2827 | 0.390 |
Why?
|
Proto-Oncogene Proteins c-ret | 2 | 2023 | 225 | 0.380 |
Why?
|
Pyrimidinones | 2 | 2024 | 385 | 0.380 |
Why?
|
Pyridones | 2 | 2024 | 809 | 0.310 |
Why?
|
Imidazoles | 2 | 2024 | 1172 | 0.300 |
Why?
|
Antineoplastic Agents | 5 | 2024 | 13632 | 0.290 |
Why?
|
Factor X | 1 | 2022 | 64 | 0.200 |
Why?
|
Mastocytosis, Systemic | 1 | 2023 | 102 | 0.200 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2023 | 2426 | 0.190 |
Why?
|
Vaccines | 1 | 2010 | 835 | 0.190 |
Why?
|
Immunotherapy | 2 | 2023 | 4642 | 0.190 |
Why?
|
Mastocytosis | 1 | 2023 | 150 | 0.190 |
Why?
|
Adenocarcinoma | 1 | 2018 | 6341 | 0.180 |
Why?
|
Proto-Oncogene Proteins | 2 | 2023 | 4513 | 0.160 |
Why?
|
Proto-Oncogene Proteins B-raf | 3 | 2024 | 2054 | 0.140 |
Why?
|
Carboplatin | 1 | 2019 | 793 | 0.130 |
Why?
|
Anaphylaxis | 1 | 2023 | 758 | 0.130 |
Why?
|
Morpholines | 1 | 2019 | 581 | 0.130 |
Why?
|
Aminopyridines | 1 | 2019 | 573 | 0.120 |
Why?
|
Humans | 26 | 2024 | 761208 | 0.120 |
Why?
|
Remission Induction | 1 | 2018 | 2392 | 0.100 |
Why?
|
Oximes | 2 | 2024 | 303 | 0.100 |
Why?
|
Tumor Cells, Cultured | 1 | 2019 | 6124 | 0.100 |
Why?
|
Mice, Inbred BALB C | 1 | 2019 | 6199 | 0.090 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2018 | 1605 | 0.090 |
Why?
|
Molecular Targeted Therapy | 2 | 2019 | 2813 | 0.090 |
Why?
|
Genotype | 1 | 2023 | 12985 | 0.080 |
Why?
|
RNA-Binding Proteins | 2 | 2022 | 1855 | 0.070 |
Why?
|
Genomics | 1 | 2023 | 5828 | 0.070 |
Why?
|
Prostatic Neoplasms | 1 | 2010 | 11101 | 0.070 |
Why?
|
Tumor Suppressor Proteins | 2 | 2024 | 2803 | 0.070 |
Why?
|
Neoplasm, Residual | 2 | 2024 | 1008 | 0.070 |
Why?
|
Cell Line, Tumor | 5 | 2024 | 16952 | 0.060 |
Why?
|
Phenotype | 1 | 2023 | 16575 | 0.060 |
Why?
|
Mice | 6 | 2024 | 81326 | 0.060 |
Why?
|
Animals | 8 | 2024 | 168079 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9278 | 0.060 |
Why?
|
Transcription Factors | 1 | 2024 | 12099 | 0.060 |
Why?
|
Focal Adhesion Kinase 1 | 1 | 2024 | 120 | 0.060 |
Why?
|
Cell Cycle Proteins | 2 | 2018 | 3446 | 0.060 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 1 | 2024 | 185 | 0.060 |
Why?
|
Neoplasm Staging | 3 | 2024 | 11119 | 0.050 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2024 | 517 | 0.050 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2023 | 294 | 0.050 |
Why?
|
Aged | 4 | 2024 | 169288 | 0.050 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2024 | 252 | 0.050 |
Why?
|
Tryptases | 1 | 2023 | 176 | 0.050 |
Why?
|
Treatment Outcome | 2 | 2019 | 64681 | 0.050 |
Why?
|
Signal Transduction | 2 | 2024 | 23416 | 0.050 |
Why?
|
Lymphatic Metastasis | 1 | 2010 | 2913 | 0.050 |
Why?
|
Cytidine Deaminase | 1 | 2023 | 242 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2024 | 636 | 0.050 |
Why?
|
Male | 6 | 2024 | 360693 | 0.050 |
Why?
|
Prostate-Specific Antigen | 1 | 2010 | 2465 | 0.040 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2024 | 858 | 0.040 |
Why?
|
Melanoma | 1 | 2019 | 5694 | 0.040 |
Why?
|
Genes, Tumor Suppressor | 1 | 2024 | 1057 | 0.040 |
Why?
|
Tumor Microenvironment | 2 | 2024 | 3873 | 0.040 |
Why?
|
Sodium-Phosphate Cotransporter Proteins, Type IIb | 1 | 2018 | 10 | 0.040 |
Why?
|
Syndecan-4 | 1 | 2018 | 45 | 0.040 |
Why?
|
beta Catenin | 2 | 2017 | 1042 | 0.040 |
Why?
|
Middle Aged | 4 | 2024 | 220853 | 0.040 |
Why?
|
Sialyltransferases | 1 | 2018 | 83 | 0.040 |
Why?
|
Female | 7 | 2024 | 392544 | 0.040 |
Why?
|
Combined Modality Therapy | 1 | 2010 | 8519 | 0.040 |
Why?
|
Epithelial Cells | 1 | 2010 | 3671 | 0.040 |
Why?
|
Subcellular Fractions | 1 | 2018 | 524 | 0.040 |
Why?
|
Prognosis | 1 | 2018 | 29687 | 0.040 |
Why?
|
NIH 3T3 Cells | 1 | 2018 | 667 | 0.030 |
Why?
|
Mast Cells | 1 | 2023 | 1392 | 0.030 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2024 | 1746 | 0.030 |
Why?
|
Ecosystem | 1 | 2020 | 489 | 0.030 |
Why?
|
Endosomes | 1 | 2018 | 518 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2024 | 3592 | 0.030 |
Why?
|
Allergens | 1 | 2023 | 1433 | 0.030 |
Why?
|
T-Lymphocytes | 2 | 2024 | 10203 | 0.030 |
Why?
|
Up-Regulation | 1 | 2023 | 4111 | 0.030 |
Why?
|
Cell Count | 1 | 2018 | 1831 | 0.030 |
Why?
|
Apoptosis | 2 | 2022 | 9477 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2018 | 1822 | 0.030 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2017 | 655 | 0.030 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2024 | 2897 | 0.030 |
Why?
|
Mice, SCID | 1 | 2018 | 2621 | 0.030 |
Why?
|
Microtubule-Associated Proteins | 1 | 2018 | 1075 | 0.030 |
Why?
|
ras Proteins | 1 | 2018 | 1055 | 0.030 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2017 | 899 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2024 | 11733 | 0.030 |
Why?
|
DNA-Binding Proteins | 1 | 2010 | 9566 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2020 | 2011 | 0.030 |
Why?
|
HEK293 Cells | 1 | 2018 | 4243 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2451 | 0.020 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2010 | 322 | 0.020 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2010 | 242 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2017 | 8530 | 0.020 |
Why?
|
Antigens, CD | 1 | 2018 | 4009 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2024 | 9187 | 0.020 |
Why?
|
Phosphorylation | 1 | 2018 | 8300 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2022 | 12747 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2017 | 6486 | 0.020 |
Why?
|
Cell Line | 1 | 2020 | 15545 | 0.020 |
Why?
|
Wnt Proteins | 1 | 2010 | 720 | 0.020 |
Why?
|
Macrophages | 1 | 2020 | 5753 | 0.020 |
Why?
|
Neoplasms | 1 | 2013 | 22140 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2018 | 5782 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2010 | 3091 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2010 | 20982 | 0.010 |
Why?
|
Disease Progression | 1 | 2019 | 13511 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2017 | 10422 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2010 | 3777 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2010 | 3412 | 0.010 |
Why?
|
Adult | 2 | 2024 | 221119 | 0.010 |
Why?
|
Cell Movement | 1 | 2010 | 5195 | 0.010 |
Why?
|